C-reactive protein, APOE genotype and longitudinal cognitive change in an older population

Age and Ageing

Volumn 43, Issue 2, 2014, Pages 289-292

  Lima, Thomas A S ^a   Adler, Amanda L ^b   Minett, Thais ^c   Matthews, Fiona E ^d   Brayne, Carol ^c   Marioni, Riccardo E ^c,e  

^a Hospital de Base de Brasilia   (Brazil)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MRC BIOSTATISTICS UNIT   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

APOE; C reactive protein; Cognitive decline; Older people; Older population

Indexed keywords

APOLIPOPROTEIN E4; C REACTIVE PROTEIN;

AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; GENOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SMOKING;

APOE; C-REACTIVE PROTEIN; COGNITIVE DECLINE; OLDER PEOPLE; OLDER POPULATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COGNITION; COGNITION DISORDERS; FEMALE; GENOTYPE; HUMANS; INFLAMMATION MEDIATORS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; ODDS RATIO; PHENOTYPE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; TIME FACTORS; UP-REGULATION;

EID: 84896731249     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/aft193     Document Type: Article

References (10)

1. Teunissen CE, van Boxtel MP., Bosma H et al. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 2003; 134: 142-50.
2. Marioni R.E., Stewart M.C., Murray G.D. et al. Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia. Psychosom Med 2009; 71: 901-6.
3. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002; 52: 168-74.
4. Silverman JM, Beeri MS, Schmeidler J et al. C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects. Age Ageing 2009; 38: 237-41.
5. Silverman JM, Schmeidler J, Beeri MS et al. C-reactive protein and familial risk for dementia: a phenotype for successful cognitive aging. Neurology 2012; 79: 1116-23.
6. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 2007; 69: 979-85.
7. Brayne C, McCracken C, Matthews FE. Cohort profile: the Medical Research Council Cognitive Function and Ageing Study (CFAS). Int J Epidemiol 2006; 35: 1140-5.
8. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-9.
9. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
10. Buchman AS, Bennett DA. High CRP with 'normal' cognition: a resilient phenotype in old age. Neurology 2012; 79: 1078-9.